Peroxisomal enzymes and 8-hydroxydeoxyguanosine in rat liver treated with perfluorooctanoic acid

Disease Markers

Volumn 19, Issue 1, 2004, Pages 19-25

  Abdellatif, Awad ^a   Al tonsy, Ahmad H ^b,e   Awad, Mahmoud E ^c   Roberfroid, M ^d   Khan, M Nezam Ullah ^a  

^a Garyounis Faculty of Medicine   (Libyan Arab Jamahiriya)

^b BENHA UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY   (Egypt)

^d Ecole de Pharmacie   (Belgium)

^e Pathology Department ^*  (Egypt)

Author keywords

(DEN); 2 acetylaminofluorene (2 AAF); Diethylnitrosamine; Hepatocellular carcinoma (HCC); Perfluorooctanoic acid (PFOA)

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACYL COENZYME A OXIDASE; CARBON TETRACHLORIDE; CATALASE; DIETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE; PERFLUOROOCTANOIC ACID; PEROXISOME PROLIFERATOR; TUMOR PROMOTER;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL DIET; CONTROLLED STUDY; DNA ISOLATION; ENZYME ACTIVITY; LIVER CANCER; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RAT;

ANIMALIA; RODENTIA;

EID: 1642574275     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/135859     Document Type: Article

References (36)

1. A. Abdellatif, V. Preat, J. Vamecq, R. Nilsson and M. Roberfroid, Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4 dichlorophenoxyacetic acid, 2,4,5 dichlorophenoxyacetic acid, perfluoroocatanoic acid and nafinopin, Carcinogenesis 11 (1990), 1899-1902.
2. P. Baudhum, H. Beaufay, Y. Rahman-Li, O. Sellinger, R. Wattiaux, P. Jacques and C. de Duve, Tissue fractionation studies: intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat liver tissue, Biochem. J. 92 (1964), 179-184.
3. J. Berthiaume and K. Wallace, Perflourooctanoate, Perfluoroactanesulfate, and N-ethylperfluoroactanesulfanamidoethanol, peroxisome proliferation and mitochondrialbiogenesis, Toxicol. Lett. 129 (2002), 23-32.
4. J. Christopher, P. Steven and S. Anya, General role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators, Ann. Rev. Pharmacol. Toxicol. 40 (2000), 491-518.
5. J. Conway, R. Cattley, J. Popp and B. Butterwath, Possible mechanisms in hepatocarcinogenesis by peroxisome proliferator Di (2-ethylhexyl) phthalates, Drug Metabolism Rev. 21 (1989), 65-102.
6. B. Elliott and C. Elcombe, Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators, Carcinogenesis 8 (1987), 1213-1218.
7. G. Guilbaut, P. Brignac and M. Juneau, New substance for flurometric determination of oxidative enzyme, Anal. Chem. 40 (1968), 1256-1263.
8. S. Goel, N. Lawani and J. Reddy, Peroxisome proliferation and lipid proxidation in rat liver, Cancer Res. 46 (1986), 1324-1330.
9. S. Horie and T. Suga, Different regulation of hepatic peroxisomal B-oxidation activity in rat treated with clofibrate and partialy hydrogenated marine oil, Biochem. Biophys. Res. Commun. 166 (1990), 780-786.
10. C. Huang, M. Wilson, L. Lay, C. Chow, L. Roberson and H. Glanert, Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid, Cancer Lett. 87 (1994), 223-228.
11. W. Huber, B. Grasl-Kraupp and R. Schulte-Herman, Hepatocarcinogenic potential of di (2-ethylhexyl) phthalate in rodents and its implications on human risk, Crit. Rev. Toxicol. 26 (1990), 365-481.
12. F. Ikeda, K. Aiba, K. Fukuda and M. Tanaka, The modulation of peroxisome poliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids, J. Biochem. 98 (1985), 475-482.
13. U. Intrasuksri, M. Rangwala, M. O'Brien, J. Noonan and D. Feller, Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids, Gen. Pharmacol. 31 (1998), 187-197.
14. H. Kasai, Y. Okado, S. Nishimura, M. Rao and J. Reddy, Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator, Cancer Res. 49 (1989), 2603-2605.
15. S. Kim, J. Hong, S. Janf, W. Kang, H. Yoo and Y. Yun, Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats, Toxicol. Sci. 23 (1989), 113-119.
16. M. Lans, J. de-Gerlache, H. Taper, V. Prseat and N. Roberfroid, Phenobarbital as a promoter in the initiation-selection process of experimental rat hepatocarcinogenesis, Carcinogenesis 4 (1983), 141-144.
17. O. Lowry, N. Rosebrough, A. Farr, R.J. Randall, Protein measurement with Folin phenol reagent, J. Biol. Chem. 193 (1951), 256.
18. K. Neubauer, T. Knittel, T. Armbrust and G. Ramadori, Accumulation of fibrinogen/fibrin during short-term and long-term rat liver injury, Gastroenterology 108 (1995), 1124-1135.
19. T. Panaretaki, I. Shabalina, D. Grander, M. Shoshan and J. De Pierre, Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, Toxicol. Appl. Pharmacol. 173 (2001), 56-64.
20. I. Pastoor, K. Lee, M. Perri and P. Gillies, Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation, Exp. Mol. Pathol. 47 (1987), 98-109.
21. C. Peraino, R. Fry and E. Staffeldt, Reduction and enhancement by Phenobarbital of hepatocarcinogenesis induced in the rats by 2-acetylaminofluorene, Cancer Res. 31 (1971), 1506-1512.
22. H. Pitot, L. Bansness and T. Goldworthy, Biochemical characterization of stages of hepatocarcinogenesis after single dose of diethylnitrozamine, Nature 271 (1978), 456-458.
23. V. Preat, J. de Gerlache, M. Lans, H. Taper and M. Roberfroid, Comparative analysis of the effect of phenobarbital, dichlorophenyltrichloroethane, butylated hydroxytoluene and nafenopin, Carcinogenesis 4 (1986), 1021-1029.
24. M. Rao and J. Reddy, An overview of peroxisome proliferator-induced hepatocarcinogenesis, Environ. Health Perspect. 93 (1991), 205-209.
25. J. Reddy and S. Qureshi, Tumoriginicity of the hypolipidemic peroxisome proliferators, clofibrate in rat, Br. J. Cancer 40 (1979), 476-482.
26. J. Reddy, D. Azarnoff and C. Hignite, Hypolipidemic hepatic peroxisome proliferators form a novel clew of chemical carcinogens, Nature 283 (1980), 397-398.
27. J. Reddy, N.D. Lalwani, M. Reddy and S.A. Qureshi, Excessive accumulation of autofluorescent lipofusion in the liver during hepatocarcinogenesis by methylclofenapate and other hypolipidemic peroxisome proliferators, Cancer Res. 42 (1982), 259-266.
28. J. Reddy and N.D. Lalwani, Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipedemic drugs and industrial plasticizers to human CRC, Crit. Rev. Toxicol. 12 (1983), 1-58.
29. J. Reddy, S. Goel, M. Nemali, J. Carrino, T. Laffler, M. Reddy, S. Sperbeck, T. Osumi, T. Hashimoto, N. Lalwani and M. Roa, Transcriptional regulation of peroxisomal fatty acyl CoA oxidase and enoyl CoA hydratase and 3-hydroxyacyl CoA dehydrogenase in rat liver by peroxisome proliferators, Proc. Natl. Acad. Sci. 83 (1986), 1747-1751.
30. J. Reddy and M. Rao, Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis, Mutat. Res. 214 (1989), 63-68.
31. M. Roberfroid, From normal cell to cancer: an overview introducing the concept of modulation of carcinogenesis, in: Concepts and Theories in Carcinogenesis, A. Meskens, P. Ebbesen and A. Burmy, eds, Elsevier Science, Amsterdam, 1987, pp. 157-167.
32. K. Sai-kato, A. Takagi, T. Umemura, R. Hasegawa and Y. Kurokawa, Role of oxidative stress in non-genotoxic carcinogenesis with special reference to liver tumors induced by peroxisome proliferators, Biomed. Environ. Sci. 8(3) (1995), 269-279.
33. R. Schulte-Hermann, Tumor promotion in the liver, Arch. Toxicol. 57 (1995), 147-158.
34. A. Takagi, K. Sai, T. Umemura, R. Hasegawa and Y. Kurokawa, Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats, Cancer Lett. 57 (1991), 55-60.
35. J. Vamecq, F. Van-Hoof, Implication of a peroxisomal enzyme in the catabolism of glutamyl-CoA, Biochem. J. 221 (1984), 203-211.
36. J. Ward, J. Rice, D. Creasia, P. Lynch and C. Riggs, Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular mice carcinoma, Carcinogenesis 4 (1983), 1020-1029.